No headlines found.
Xylo Technologies Files its 2023 Annual Report on Form 20-F
Globe Newswire (Mon, 22-Apr 4:05 PM ET)
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.
Xylo Technologies Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol XYLO.
As of May 8, 2024, XYLO stock price declined to $1.80 with 10,839 million shares trading.
XYLO has a market cap of $3.04 million. This is considered a Sub-Micro Cap stock.
XYLO support price is $1.72 and resistance is $2.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XYLO stock will trade within this expected range on the day.